Navigation Links
Precious metal could lead to next generation of cancer treatments
Date:12/8/2008

A precious metal which has never before been used in a clinical setting is being developed as an anti-cancer agent by University of Warwick researchers.

The metal, osmium, is closely related to platinum, which is widely used to treat cancers in the form of the drug cisplatin. Most famously, the cyclist Lance Armstrong was treated with cisplatin for testicular cancer.

Now the researchers, based in the Department of Chemistry, at the University of Warwick, are working closely with Warwick Ventures, the university's technology transfer office, to seek partners to help develop the potential of osmium through more extensive biological tests. The team will be presenting their work on 9 December at the national university technology showcase event, Bioversity.

Professor Peter Sadler, of the Department of Chemistry, explained: "Although cisplatin has been proven to be a very successful treatment; it is not useful for all kinds of cancer. It is also quite a toxic therapy, which can produce side effects and, from a clinical point of view, cells can also become resistant to platinum."

Osmium, with its special chemical properties, offers a new potential solution to an unmet clinical need. It has shown huge promise in treating several different types of cancer cell, including ovarian and colon cancers which have been developed and tested in the laboratory. The metal also has another advantage in that it is a much cheaper alternative to platinum.

Professor Sadler, along with post-graduate researcher Sabine van Rijt, is working to develop new compounds using Osmium, which they hope will lead to the development of drugs which could be used in combination therapies alongside existing drugs such as cisplatin.

"The compounds we have been developing are very promising," says Sabine van Rijt. "We're building a picture of how different compounds might interact with DNA in cancer cells. By making changes to the coating, or ligand,
'/>"/>

Contact: Peter Dunn
p.j.dunn@warwick.ac.uk
44-024-765-23708
University of Warwick
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Precious Time - Scientists discover how long heart failure patients can expect to live
2. Mothers Day Gives Woman Reason to Celebrate Lifes Most Precious Gift
3. MIPSolutions, Inc. Reduces Expense and Development Time Associated With Precious Metal Extraction
4. Cornell efficiency experts seek to save precious minutes in deploying ambulances
5. Donate Blood - A Simple and Precious Lifegiving Gift
6. Biosensors to probe the metals menace
7. Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones
8. Heavy metal slips down UK air quality charts
9. Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases
10. New sensor system improves detection of lead, heavy metals
11. Novel organic metal hybrids that will revolutionize materials science and chemical engineering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... NY (PRWEB) November 24, 2014 From embedded ... progressive world of fitness technology will take center stage at ... Digital Times at the 2015 International CES® , ... the Venetian, Level 2, Bellini 2004). The bond between fitness ... into being less about devices and more about the human ...
(Date:11/24/2014)... 2014 Volpara Solutions announced today ... the 100th Annual Meeting of the Radiology Society ... (RSNA Booth 1752 – South Hall). Volpara Solutions ... the rest of its innovative suite of quantitative ... enable personalized measurements of volumetric density, patient-specific dose, ...
(Date:11/24/2014)... Dallas, TX (PRWEB) November 24, 2014 ... ADP ribose polymerase (PARP) and is one of the ... genetically vulnerable to creating some types of melanoma, and ... but this also sometimes gives their malignancies a exclusive ... on PARP to fix their DNA and allow them ...
(Date:11/24/2014)... 24, 2014 Mental health issues ... They break up families, ruin careers, and generally ... for those that suffer,” says Hardy Nutritionals® ... showing that our specialized nutritional treatments can reverse ... on “Mind Over Matter”, the premiere episode of ...
(Date:11/24/2014)... 24, 2014 Gersowitz Libo & Korek, P.C., ... received national Tier recognition in the 2015 Edition of U.S. ... ranking signals a unique combination of quality law practice and ... receive this honor and especially grateful to our clients whose ... and ranking possible,” said Jeff S. Korek, senior partner at ...
Breaking Medicine News(10 mins):Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 2Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 3Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 4Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 2Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 3Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 2Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 3Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 4Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2
... Campaigners have announced that there is a lack of specialist ... to the Scottish Drugs Forum, in spite of the rise ... there are only 2 publicly funded centres specifically for cocaine ... Aberdeen and Edinburgh. 1-in-5 drug-related deaths in greater Glasgow area ...
... have identified the gene that may be responsible for glue ear ... is the major cause of hearing// impairment in children. This condition ... 50% of the kids less than one year old are affected ... bouts. Though the involvement of genes in otitis media was already ...
... of the Health Ministers of chikungunya-affected States will be oganised ... capital today//. ,The agenda is to come ... affected more than 1.3 million people in India. Chikungunya has ... Anbumani Ramadoss will chair the meeting of the Health Ministers ...
... Government plans to reform the unwieldy Pharmaceutical Benefits Scheme ... into making more new medicines available to more Australians. ... Gullotta said reports that Health Minister Tony Abbott is ... effectively are a welcome start to much-needed PBS reforms. ...
... Nine people, including three women and three kids, were killed ... consumed //rotten fish at a government-run relief camp in Chhattisgarh's ... sent late Monday to the relief camp in Injeram village ... ,"A group of 50 tribals brought rotten fish ...
... of Medicine, the Regenstrief Institute, Inc. and the Richard ... research regarding guidelines that control antibiotics and antibiotic resistance ... guide lines which have been laid down to control ... antibiotic resistance as well. , ,The researchers ...
Cached Medicine News:Health News:‘Evil’ Gene causing ‘glue ear’ in 2Health News:AMA Welcomes Government Plans to Reform PBS 2Health News:Efforts to Check Uncontrolled use of Antibiotics and Antibiotic Resistance 2
(Date:11/22/2014)... , Nov. 22, 2014  New data demonstrates that ... most common form of female sexual dysfunction, Hypoactive Sexual ... or driving performance in premenopausal women when taken at ... Society of North America,s (SMSNA) ... . SMSNA accepted this study ...
(Date:11/22/2014)... , Nov. 21, 2014 Statistics released from ... drunk driving increase astronomically during the holidays, beginning with ... many cities. The data, highlighted ... Systems as part of their annual Sober ... a picture of high-risk drinking and increased rates of ...
(Date:11/22/2014)... , Nov. 21, 2014 Many power ... the growing influence of patients in the biopharmaceutical ... interactions. Now, more than ever, understanding how to ... medical products is essential. According ... LLC, benchmarked companies spent about two-thirds of their ...
Breaking Medicine Technology:Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3Alarming Stats Show Holiday Drinking an Issue for Many 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2
... Automate the Interface between Health Assessments for ... Customized Care Treatment Plans, AUBURN, Calif., Jan. ... the development of medical management software,applications through acuity ... three new clinical content programs, referred to as,the ...
... the Journal of the ... American Cancer Society, ... CTIC ; MTAX) announced today that results of a phase ... of radioimmunotherapy (RIT) to chemotherapy for previously,untreated patients with non-follicular ...
Cached Medicine Technology:TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY 2TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY 3Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 2Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 3Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 4Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 5
... The remote vision controls ... NP-3S chart projector from the ... the autorefraction measurements can be ... via wireless data transfer. The ...
... testing provides clinically beneficial information in ... Dark adaptometry is useful in the ... senile miosis, high myopia, vitamin-A deficiency, ... whole-field scotopic sensitivity has been shown ...
... 3000 is the most advanced visual ... accurate measurements of retinal and optic ... software available drives this powerful computer-controlled ... adjustable contrast pattern stimulation, rapid Ganzfeld ...
The STALIF stand-alone anterior lumbar fusion cage is the latest product development from Surgicraft. STALIF is the natural evolution of the Hartshill Horseshoe, which has over 10 years clinical suc...
Medicine Products: